(redirected from inotropic agent)
Also found in: Dictionary, Medical, Legal, Financial, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for agent

Synonyms for agent

that by which something is accomplished or some end achieved

a person who secretly observes others to obtain information

Synonyms for agent

any agent or representative of a federal agency or bureau

the semantic role of the animate entity that instigates or causes the happening denoted by the verb in the clause

References in periodicals archive ?
New positive inotropic agents with higher safety margins and stronger effects on cardiac contractility have been introduced in human and veterinary cardiology during the last 20 years (3) and their use must be explored in the avian patient.
Other inotropic agents are dobutamine and milrinone.
Levosimendan is a recently introduced inotropic agent, which improves cardiac contractility without increasing myocardial oxygen consumption.
Following admission, he was treated with intravenous antibiotic therapy (imipenem 500 mg every 6 h, teicoplanin 400 mg every 12 h, and vancomycin 1000 mg every 12 h), fluid resuscitation with crystalloids and inotropic agent.
Levosimendan, a new inotropic agent with novel cardioprotective effects, is emerging as a therapeutic option for both intraoperative cardiac support as well as organ protection.
When intravenous vasoactive medications are required for acute decompensated heart failure, patients who receive a vasodilator or natriuretic peptide are more likely to survive than are those who receive a positive inotropic agent, reported William T.
This herb is a positive inotropic agent that increases contractility of the heart," said Dr.
Levosimendan is a new promising inotropic agent for therapy of advanced HF It has more favorable effects regarding improvement of HF symptoms, neurohormonal activation and hemodynamics compared to conventional positive inotropic agents.
Short-term intravenous use of the inotropic agent milrinone does not improve outcomes in patients with exacerbations of chronic heart failure, reported Dr.
He led the research team that developed the injectable inotropic agent, PRIMACOR (milrinone), for the acute treatment of CHF.
In addition, after the development of sternal dehiscence, these techniques were associated with similar mortality rates and postoperative outcomes (time to sternal refixation, prolonged ICU stay, intraaortic balloon counterpulsation use and chest re-exploration inotropic agent use and postoperative cerebrovascular accident).